Biochemical markers in first-episode psychosis: A case-control study
Medical Journal Armed Forces India · 2026-05 · 82 (3) · 350-355
DOI: 10.1016/j.mjafi.2026.01.007 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Medical Journal Armed Forces India, 2026-05. Verfasst von Ritwik Mishra und 6 weiteren Autor:innen. Beteiligte Einrichtung: Assistant Professor (Psychiatry), 166 Military Hospital, C/o 56 APO, India. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Defence Research and Development Organisation.
Abstract (Originalsprache)
Background
It is being increasingly realized that immunological dysregulation and alteration of levels of cytokines play an important role in the etiology of psychotic symptoms, particularly of first-episode psychosis (FEP). Earlier studies have theorized that disrupted levels of interleukin-6 (IL-6) and interleukin-10 (IL-10) and other cytokines like C-reactive protein and tumor necrosis factor-alpha (TNF-α) play a role in symptom development in FEP patients. The study was done to evaluate serum levels of IL-6, IL-10, and IL-10-to-IL-6 ratio in FEP patients versus a healthy control population.
Methods
A case-control study was conducted with 120 individuals (60 FEP patients and 60 healthy controls age and sex matched) at a tertiary care facility in Western Maharashtra from January 2023 to December 2023. The serum levels of IL-6 and IL-10 were analyzed using enzyme-linked immunosorbent assay. Independent t-tests were used to analyze data for continuous variables and odds ratios (ORs) with 95% confidence intervals (CIs).
Results
FEP patients exhibited IL-10 levels significantly higher than controls (6.39 ± 1.17 pg/mL vs 4.42 ± 0.58 pg/mL; p < 0.001) and lower IL-6 levels than controls (3.98 ± 0.56 pg/mL vs 4.31 ± 0.39 pg/mL; p < 0.001). The average IL-10-to-IL-6 ratio was also significantly different in FEP cases at 1.65 ± 0.46 and controls at 1.03 ± 0.11, with p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Assistant Professor (Psychiatry), 166 Military Hospital, C/o 56 APO, India.
- Associate Professor (Psychiatry), Command Hospital (Southern Command), Pune, India.
- Professor (Neurosurgery), Aster Royal Hospital, Muscat, Oman.
- Junior Resident (Psychiatry), Command Hospital (Southern Command), Pune, India.
- Professor (Psychiatry), Command Hospital (Eastern Command), Kolkata, India.
- Assistant Professor (Microbiology), Command Hospital (Southern Command), Pune, India.
Förderung
- Defence Research and Development Organisation
Zitieren
APA
Mishra, R., Sharma, S., Shashivadhanan, S., Niyaz, M. D., Singal, A., Bhalla, G. S., & Sharma, N. (2026). Biochemical markers in first-episode psychosis: A case-control study. Medical Journal Armed Forces India, 82(3), 350-355. https://doi.org/10.1016/j.mjafi.2026.01.007
Vancouver
Mishra R, Sharma S, Shashivadhanan S, Niyaz MD, Singal A, Bhalla GS, et al. Biochemical markers in first-episode psychosis: A case-control study. Medical Journal Armed Forces India. 2026;82(3):350-355. doi:10.1016/j.mjafi.2026.01.007
BibTeX
@article{Mishra2026,
author = {Mishra, Ritwik and Sharma, Surender and Shashivadhanan, S and Niyaz, M D and Singal, Ankit and Bhalla, G S and Sharma, Neha},
title = {Biochemical markers in first-episode psychosis: A case-control study},
journal = {Medical Journal Armed Forces India},
year = {2026},
volume = {82},
number = {3},
pages = {350--355},
doi = {10.1016/j.mjafi.2026.01.007}
}
EUVIMED